EFFECTS OF ERYTHROMYCIN ON CHEMOATTRACTANT-ACTIVATED HUMAN POLYMORPHONUCLEAR LEUKOCYTES

Citation
V. Villagrasa et al., EFFECTS OF ERYTHROMYCIN ON CHEMOATTRACTANT-ACTIVATED HUMAN POLYMORPHONUCLEAR LEUKOCYTES, General pharmacology, 29(4), 1997, pp. 605-609
Citations number
28
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
ISSN journal
03063623
Volume
29
Issue
4
Year of publication
1997
Pages
605 - 609
Database
ISI
SICI code
0306-3623(1997)29:4<605:EOEOCH>2.0.ZU;2-O
Abstract
1. Erythromycin (2-100 mu g ml(-1)) produced a concentration-related i nhibition of superoxide generation and elastase release induced by in vitro exposure of human polymorphonuclear leukocytes (PMNs) to the che motactic peptide N-formylmethionyl-leucyl-phenylalanine (FMLP; 30 nM). 2. By contrast, erythromycin (100 mu g ml(-1)) did not alter the leuk otriene B-4 production elicited by FMLP (30 nM; in the presence of thi merosal 20 mu M) or the intracellular calcium changes promoted by FMLP (30 nM; in the absence or presence of thimerosal 20 mu M). 3. These r esults indicate that by reducing chemoattractant-triggered release of oxidative and proteolytic mediators from human PMNs, erythromycin may have clinically useful antiinflammatory effects. (C) 1997 Elsevier Sci ence Inc.